Literature DB >> 16411109

Transpupillary thermotherapy for chronic central serous chorioretinopathy.

Nazimul Hussain1, Rohit Khanna, Anjli Hussain, Taraprasad Das.   

Abstract

PURPOSE: To determine whether transpupillary thermotherapy (TTT) causes resolution of neurosensory detachment associated with chronic central serous chorioretinopathy (CSCR).
METHODS: The study was a prospective interventional pilot study. All patients underwent Snellen visual acuity measurement (converted to LogMAR for analysis), slitlamp biomicroscopy, fundus examination, colour fundus photography, fluorescein and indocyanine green (ICG) angiography and optical coherence tomography (OCT). Follow-up was scheduled at 1, 2 and 3 months. Success was defined as resolution of neurosensory detachment on OCT at 3 months, and failure as persistence of the same. The primary outcome measure was resolution of OCT-measured neurosensory detachment and secondary outcome measure was change in visual acuity at the end of 3 months.
RESULTS: Fourteen eyes of 13 patients were included in the study. Twelve patients were male. The left eye was affected in seven of 14 eyes. The patients' mean age was 42.7+/-4.5 years (range 38-54 years). TTT parameters were as follows: power 156+/-47.8 mW; spot size 2.2+/-1.1 mm; duration 39.6+/-7.5 s. Following treatment, complete resolution of neurosensory detachment on OCT was seen in nine eyes (64.3%) at month 1 (P=0.004) and 11 eyes (78.6%) at months 2 and 3 (P=0.001). Three eyes (21.4%) had persistent subretinal fluid at month 3. Eight eyes (52.7%) had >or=3 lines of improvement (two eyes: five lines and six eyes three lines) at the final visit.
CONCLUSION: Transpupillary thermotherapy could be a therapeutic option in patients with chronic CSCR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16411109     DOI: 10.1007/s00417-005-0175-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  19 in total

Review 1.  Idiopathic central serous chorioretinopathy.

Authors:  D Hussain; J D Gass
Journal:  Indian J Ophthalmol       Date:  1998-09       Impact factor: 1.848

2.  Transpupillary thermotherapy for circumscribed choroidal hemangiomas: first choice in therapy.

Authors:  C Mosci; A Polizzi; M Zingirian
Journal:  Eur J Ophthalmol       Date:  2001 Jul-Sep       Impact factor: 2.597

3.  Photodynamic therapy in chronic central serous chorioretinopathy.

Authors:  M Battaglia Parodi; S Da Pozzo; G Ravalico
Journal:  Retina       Date:  2003-04       Impact factor: 4.256

4.  Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation.

Authors:  R S Newsom; J C McAlister; M Saeed; J D McHugh
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

5.  Pathogenesis of disciform detachment of the neuroepithelium.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1967-03       Impact factor: 5.258

6.  Central serous chorioretinopathy and indocyanine green angiography.

Authors:  F C Piccolino; L Borgia
Journal:  Retina       Date:  1994       Impact factor: 4.256

7.  Digital indocyanine green videoangiography of central serous chorioretinopathy.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; A Ho; D Orlock
Journal:  Arch Ophthalmol       Date:  1994-08

8.  Long-term follow-up of central serous chorioretinopathy.

Authors:  C M Gilbert; S L Owens; P D Smith; S L Fine
Journal:  Br J Ophthalmol       Date:  1984-11       Impact factor: 4.638

9.  Photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  Felice Cardillo Piccolino; Chiara M Eandi; Luca Ventre; Roberta C Rigault de la Longrais; Federico M Grignolo
Journal:  Retina       Date:  2003-12       Impact factor: 4.256

10.  Subthreshold transpupillary thermotherapy reduces experimental choroidal neovascularization in the mouse without collateral damage to the neural retina.

Authors:  Yue Ming; Peep V Algvere; Anne Odergren; Lennart Berglin; Ingeborg van der Ploeg; Stefan Seregard; Anders Kvanta
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-06       Impact factor: 4.799

View more
  10 in total

Review 1.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

2.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

3.  Role of Transpupillary Thermotherapy in Central Serous Chorio-Retinopathy.

Authors:  V Mathur; Jks Parihar; R Maggon; S K Mishra
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 4.  Pachychoroid neovasculopathy: a type-1 choroidal neovascularization belonging to the pachychoroid spectrum-pathogenesis, imaging and available treatment options.

Authors:  Francesco Sartini; Michele Figus; Giamberto Casini; Marco Nardi; Chiara Posarelli
Journal:  Int Ophthalmol       Date:  2020-07-30       Impact factor: 2.031

Review 5.  Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options.

Authors:  Francesco Sartini; Michele Figus; Marco Nardi; Giamberto Casini; Chiara Posarelli
Journal:  Eye (Lond)       Date:  2019-03-01       Impact factor: 3.775

6.  Large-spot subthreshold transpupillary thermotherapy for chronic serous macular detachment.

Authors:  Giuseppe Lo Giudice; Valentina de Belvis; Marco Tavolato; Alessandro Galan
Journal:  Clin Ophthalmol       Date:  2011-03-14

7.  Transpupillary thermotherapy for atypical central serous chorioretinopathy.

Authors:  Ryosuke Kawamura; Hidenao Ideta; Hideyuki Hori; Kenya Yuki; Tsuyoshi Uno; Tatsurou Tanabe; Kazuo Tsubota; Tsutomu Kawasaki
Journal:  Clin Ophthalmol       Date:  2012-01-25

8.  Subthreshold Continuous Wave Autofluorescence-controlled Laser Treatment of Chronic Central Serous Chorioretinopathy.

Authors:  Hossein Ashraf; Mansooreh Jamshidian; Mohammad Reza Khalili; Mousa Zare; Anis Shamsi
Journal:  J Ophthalmic Vis Res       Date:  2018 Jul-Sep

Review 9.  Advances in the treatment of central serous chorioretinopathy.

Authors:  Marwan A Abouammoh
Journal:  Saudi J Ophthalmol       Date:  2015-01-24

10.  Pneumatic displacement with perfluoropropane gas and intravitreal tissue plasminogen activator for subretinal subfoveal hemorrhage after focal laser photocoagulation in central serous chorioretinopathy.

Authors:  Khalid Al Rubaie; Juan V Espinoza; Andres F Lasave; Dario Savino-Zari; Fernando A Arevalo; J Fernando Arevalo
Journal:  Case Rep Ophthalmol Med       Date:  2014-11-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.